Click to view the original PDF
The research report was released on August 6 to maintain the Yantai Zhenghai Bio-Tech Co.Ltd(300653) overweight rating. Guoyuan Securities Company Limited(000728) predicts that the net profit attributable to the parent company in Yantai Zhenghai Bio-Tech Co.Ltd(300653) 2021 will be 160 million yuan, with a year-on-year increase of 35.25%.
Main financial indicators and valuation
2021E
2022E
2023E
Total operating revenue (100 million yuan) 409.5 million yuan thirty-six point six nine
Net profit attributable to parent company (RMB 100 million) seventy-two point six three
Earnings per share (yuan) 1.331 seven hundred and thirty-two point one nine
Net assets per share (yuan) 6.728 two hundred and ten point one four
Price earnings ratio (PE) 332520
Price to book ratio (PB) 6.515 three hundred and forty-four point three two
Return on net assets (%) 19.8421 six hundred and twenty-one point five eight
Note: the data is obtained from the text of the research report.
Yantai Zhenghai Bio-Tech Co.Ltd(300653) has attracted the attention of 4 research reports of securities companies in recent month. The detailed data of the research report are shown in the table below:
Research report date
Organization abbreviation
Target price
This rating
details
2021-08-06 Soochow Securities Co.Ltd(601555) – buy comments on 2021 interim report: the performance meets our expectations and is optimistic about the medium and long-term development of the company
2021-08-06 Guoyuan Securities Company Limited(000728) – holdings increase Yantai Zhenghai Bio-Tech Co.Ltd(300653) comments on the 2021 semi annual report: the backlog demand of fist products is released, driving performance growth
2021-08-06 The Pacific Securities Co.Ltd(601099) 74 purchase comments on 2021 semi annual report: demand continues to recover and performance grows rapidly
On August 5, 2021, Ping An Securities – the recommended company’s performance met expectations, and the core varieties recovered well
Disclaimer: This article is based on big data production and is for reference only. It does not constitute any investment suggestions. Therefore, the operator shall bear the operational risk.
